These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2734653)

  • 1. [Preventing possible adverse effects of prophylactic measures].
    Oganov RG; Gundarov IA
    Sov Zdravookhr; 1989; (1):17-23. PubMed ID: 2734653
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary heart disease risk factors and antihypertensive drug selection.
    Kaplan NM
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S187-9. PubMed ID: 6177954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventive measures for practically healthy men of working age].
    Fomina RF; Kozlov ID; Avramenko TV; Apanasevich VV
    Sov Zdravookhr; 1991; (8):44-7. PubMed ID: 1835803
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of heart attacks. A multifactorial preventive trial in Gothenburg, Sweden.
    Werkö L
    Ann Clin Res; 1979 Apr; 11(2):71-9. PubMed ID: 453782
    [No Abstract]   [Full Text] [Related]  

  • 5. [The continuing debate on the treatment of hypercholesterolemia in the primary prevention of coronary disease. What did cholesterol do to deserve that?].
    Ros Rahola E
    Med Clin (Barc); 1997 Oct; 109(14):542-5. PubMed ID: 9508615
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of diabetes as a cardiovascular risk factor.
    Plouin PF
    Int J Clin Pract Suppl; 2000 May; (110):3-8. PubMed ID: 10912301
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study.
    Tomasik T; Jozwiak J; Windak A; Rygiel K; Mastej M; Smithson WH; Mathers N; Tomaszewski M; Kaess BM; Tykarski A; Konduracka E; Grzeszczak W; Lukas W
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):287-96. PubMed ID: 21450675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary cardiopathy. The epidemiological and preventive aspects].
    Guimarães A
    Arq Bras Cardiol; 1992 Jul; 59(1):5-11. PubMed ID: 1341147
    [No Abstract]   [Full Text] [Related]  

  • 10. [Risk factors and coronary heart disease prevention in selected Lódź population--part II].
    Kowalski J; Kos M; Gburek J; Wrocławski W; Pawlicki L
    Pol Merkur Lekarski; 2005 Dec; 19(114):749-53. PubMed ID: 16521415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary risk factors for coronary heart disease: their role in prevention.
    Wilhelmsen L
    Med J Malaysia; 1977 Jun; 31(4):296-301. PubMed ID: 927236
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of hypercholesterolemia revisited.
    Wiggins BS
    Manag Care Interface; 2001 Jan; 14(1):58-66, 72. PubMed ID: 11214536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paradox of cholesterol and stroke.
    Amarenco P; Steg PG
    Lancet; 2007 Dec; 370(9602):1803-4. PubMed ID: 18061038
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of the 5-year program of multi-factorial prevention of ischemic heart disease in men].
    Meĭmanaliev TS; Shleĭfer EA; Madaminov IaK; Gil'fanova VSh; Aĭtmurzaeva GT; Finger EM; Ismailova ChS; Koshaliev EK; Iaroslavtseva OS; Podgurskaia LP
    Sov Med; 1990; (12):57-9. PubMed ID: 2151491
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk factors of ischemic heart disease in practically healthy persons with different physical work capacities and their correction by physical exercise].
    Pirogova EA
    Ter Arkh; 1988; 60(1):20-3. PubMed ID: 3363501
    [No Abstract]   [Full Text] [Related]  

  • 17. In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?
    Adelman A
    J Fam Pract; 2001 Nov; 50(11):924. PubMed ID: 11711002
    [No Abstract]   [Full Text] [Related]  

  • 18. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of coronary disease: an update.
    Hataway J; Oberman A
    Ala J Med Sci; 1984 Jan; 21(1):58-67. PubMed ID: 6367518
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.